A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

Researchers develop targeted polymersomes loaded with methotrexate for the treatment of gestational choriocarcinoma, ...

Choriocarcinoma is caused by abnormal tissue that develops after sperm fertilizes an egg inside the womb. Anyone with a uterus can develop this type of tumor, and there are certain risk factors to ...

Findings of the study into choriocarcinoma, which occurs in the United States at a rate of about four cases per 100,000 pregnancies, were published in Small Science. Typically starting in the ...

Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma. Functional and oncological outcome of primary nerve sparing retroperitoneal lymph node dissection in ...

Findings of the study into choriocarcinoma, which occurs in the United States at a rate of about four cases per 100,000 pregnancies, were published in Small Science. Typically starting in the ...

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...